184 related articles for article (PubMed ID: 37828981)
41. Senescence-Associated Molecules and Tumor-Immune-Interactions as Prognostic Biomarkers in Colorectal Cancer.
Kellers F; Fernandez A; Konukiewitz B; Schindeldecker M; Tagscherer KE; Heintz A; Jesinghaus M; Roth W; Foersch S
Front Med (Lausanne); 2022; 9():865230. PubMed ID: 35492321
[TBL] [Abstract][Full Text] [Related]
42. TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling.
Hou Z; Guo K; Sun X; Hu F; Chen Q; Luo X; Wang G; Hu J; Sun L
Mol Cancer; 2018 Dec; 17(1):172. PubMed ID: 30541550
[TBL] [Abstract][Full Text] [Related]
43. mRNAsi-related metabolic risk score model identifies poor prognosis, immunoevasive contexture, and low chemotherapy response in colorectal cancer patients through machine learning.
Weng M; Li T; Zhao J; Guo M; Zhao W; Gu W; Sun C; Yue Y; Zhong Z; Nan K; Liao Q; Sun M; Zhou D; Miao C
Front Immunol; 2022; 13():950782. PubMed ID: 36081499
[TBL] [Abstract][Full Text] [Related]
44. Senescence-based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies.
Lv MY; Cai D; Li CH; Chen J; Li G; Hu C; Gai B; Lei J; Lan P; Wu X; He X; Gao F
MedComm (2020); 2023 Aug; 4(4):e333. PubMed ID: 37502611
[TBL] [Abstract][Full Text] [Related]
45. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
46. Cellular senescence-related long noncoding ribonucleic acids: Predicting prognosis in hepatocellular carcinoma.
Huang H; Yao H; Wei Y; Chen M; Sun J
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1791. PubMed ID: 36726348
[TBL] [Abstract][Full Text] [Related]
47. Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods.
Liu Y; Cheng L; Li C; Zhang C; Wang L; Zhang J
Sci Rep; 2021 Jul; 11(1):15040. PubMed ID: 34294834
[TBL] [Abstract][Full Text] [Related]
48. The Senescence-Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic Cancer.
Hua H; Zheng C; Fan J; Li X; Xie W; Chen J; Yu C
Biomed Res Int; 2022; 2022():1916787. PubMed ID: 36518628
[TBL] [Abstract][Full Text] [Related]
49. A novel prognostic signatures based on metastasis- and immune-related gene pairs for colorectal cancer.
Pan B; Yue Y; Ding W; Sun L; Xu M; Wang S
Front Immunol; 2023; 14():1161382. PubMed ID: 37180113
[TBL] [Abstract][Full Text] [Related]
50. Cellular senescence: a promising therapeutic target in colorectal cancer.
Wu Y; Xie M; Sun JH; Li CC; Dong GH; Zhang QS; Cui PL
Future Oncol; 2022 Sep; 18(30):3463-3470. PubMed ID: 36069254
[TBL] [Abstract][Full Text] [Related]
51. Lactate: A regulator of immune microenvironment and a clinical prognosis indicator in colorectal cancer.
Zhu D; Jiang Y; Cao H; Yang J; Shu Y; Feng H; Yang X; Sun X; Shao M
Front Immunol; 2022; 13():876195. PubMed ID: 36091047
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer.
Wang L; Chen X; Zhang H; Hong L; Wang J; Shao L; Chen G; Wu J
Front Immunol; 2022; 13():1014834. PubMed ID: 36389750
[TBL] [Abstract][Full Text] [Related]
53. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
[TBL] [Abstract][Full Text] [Related]
54. LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.
Liu X; Song Q; Wang D; Liu Y; Zhang Z; Fu W
Oncol Lett; 2022 Jul; 24(1):234. PubMed ID: 35720504
[TBL] [Abstract][Full Text] [Related]
55. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer.
Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL
Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393
[TBL] [Abstract][Full Text] [Related]
56. A novel identified pyroptosis-related prognostic signature of colorectal cancer.
Zheng C; Tan Z
Math Biosci Eng; 2021 Oct; 18(6):8783-8796. PubMed ID: 34814322
[TBL] [Abstract][Full Text] [Related]
57. Constructing a Tregs-associated signature to predict the prognosis of colorectal cancer patients: A STROBE-compliant retrospective study.
Ping G; Tian Y; Zhou Z
Medicine (Baltimore); 2022 Nov; 101(47):e31382. PubMed ID: 36451426
[TBL] [Abstract][Full Text] [Related]
58. CAF signature predicts the prognosis of colorectal cancer patients: A retrospective study based on bulk RNA sequencing and single-cell RNA sequencing data.
Liang C; Ji D; Qin F; Chen G
Medicine (Baltimore); 2023 Mar; 102(10):e33149. PubMed ID: 36897717
[TBL] [Abstract][Full Text] [Related]
59. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
[TBL] [Abstract][Full Text] [Related]
60. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
